LBH and cholangiocarcinoma: In addition, TCGA analysis revealed LBH overexpression in rare bile duct (cholangiocarcinoma/CHOL; +11.8-fold), neuroendocrine (pheochromocytomas and paragangliomas/PCPG; +4.3-fold), and thymus (thymoma/ THYM; +4.6-fold) cancers (Fig. S1B.i–iii).